SCHEMBL30366852

SCHEMBL30366852

CCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 1.00
PTAFR P25105 1/20 1.00
HTR1D P28221 1/20 1.00
HTR2C P28335 1/20 1.00
ADRA1B P35368 1/20 1.00
DRD3 P35462 1/20 1.00
TMEM97 Q5BJF2 1/20 1.00
MAPT P10636 1/20 0.77
ALDH1A1 P00352 2/20 0.76
SMN1; SMN2 Q16637 2/20 0.76
PRKD3 O94806 1/20 0.76
PRKCG P05129 1/20 0.76
PRKCB P05771 1/20 0.76
PRKCA P17252 1/20 0.76
PRKCH P24723 1/20 0.76
AKT1 P31749 1/20 0.76
PRKCI P41743 1/20 0.76
PRKCE Q02156 1/20 0.76
PRKCQ Q04759 1/20 0.76
PRKCZ Q05513 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30655807 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
Platelet Activating Factor SCHEMBL433361 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL30652762 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL30652521 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL34464893 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL435191 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
Platelet Activating Factor SCHEMBL2734461 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL2534238 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL30650457 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B
Platelet Activating Factor SCHEMBL1392735 1.00 ADRA1D (1.00) ADRA1DPTAFRHTR1DHTR2CADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250231190-A1 ENHANCED FLUORESCENCE SIGNAL THROUGH THE APPLICATION OF AROMATIC ADDITIVES ONTO THE MICROSCOPY SAMPLE FOR STANDARD FLUORESCENCE, FLUORESCENCE MICROSCOPY AND COMBINED FLUORESCENCE MALDI MICROSCOPY/IMAGING THE JOHNS HOPKINS UNIVERSITY 2025-07-17 US disclosed
WO-2025091079-A1 DIAGNOSTIC SIGNATURE BCAL Diagnostics Limited (AU) 2025-05-08 WO disclosed
EP-4522646-A2 APOE LIPOPROTEIN SYSTEMS Kisbee Therapeutics, Inc. (US) 2025-03-19 EP disclosed
WO-2023220387-A2 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
WO-2023205280-A1 ENHANCED FLUORESCENCE SIGNAL THROUGH THE APPLICATION OF AROMATIC ADDITIVES ONTO THE MICROSCOPY SAMPLE FOR STANDARD FLUORESCENCE, FLUORESCENCE MICROSCOPY AND COMBINED FLUORESCENCE MALDI MICROSCOPY/IMAGING THE JOHNS HOPKINS UNIVERSITY (US) 2023-10-26 WO disclosed
CN-116087482-B Biomarkers for severity typing of course of patients with 2019 novel coronavirus infection 广州国家实验室 2023-07-11 CN disclosed
CN-116087482-A Biomarkers for novel patient progression severity typing for coronavirus infection 广州国家实验室 2023-05-09 CN disclosed